NEW YORK (GenomeWeb) – Arrayit today reported a 15 percent spike in first quarter sales driven by sales of microarray instruments.

Total revenues for the three months ended March 31 were $1.1 million up from $942,916 in the first quarter of 2013.

On an earnings call President Mark Schena attributed the growth to increased customer demand for the Sunnyvale, Calif.-based company's microarray products. During the quarter, Arrayit shipped three NanoPrint microarray printers, five SpotBot microarray printers, and a Colorimetric microarray platform, Schena said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.